Literature DB >> 34984362

Commentary: The Barlow valve: Understanding disease and symmetry.

Carlos A Mestres1,2, Miguel A Piñón3, Eduard Quintana4.   

Abstract

Entities:  

Year:  2021        PMID: 34984362      PMCID: PMC8691901          DOI: 10.1016/j.xjtc.2021.10.006

Source DB:  PubMed          Journal:  JTCVS Tech        ISSN: 2666-2507


× No keyword cloud information.
Carlos A. Mestres, MD, PhD, FETCS (left), Miguel A. Piñón, MD, PhD (center), and Eduard Quintana, MD, PhD, FETCS (right) This historical summary of the main aspects of the Barlow valve helps readers to understand the complexity of this pathoanatomical and functional disease and the best approach for successful surgery. See Article page 58. Mitral valve repair is the gold standard in the surgery of degenerative mitral valve disease, a solidly established option supported by practice guidelines despite discussion. The main goal of repair is achieving valve competence. Of special interest is the complex described by the late John Barlow in 1963, known as the Barlow valve or Barlow disease. His description of late systolic murmur and malignant cardiac arrhythmias triggered by mitral valve prolapse opened a new era in the investigation of the mitral valve. The Barlow valve still poses technical challenges to surgeons due to its multifaceted pathoanatomical presentation with bileaflet involvement with abnormally thickened leaflet tissue, gross involvement of the subvalvular apparatus, and annular dilatation. The main aspects of the disease are too much leaflet tissue and abnormal annular function. Pooling this all together, one understands that correction of the Barlow valve is more complex than for other disease forms. This complexity influences outcomes, although experienced centers report freedom from reoperation for regurgitation of 85% to 90% at 10 years.6, 7, 8 In this issue of the Journal, Barlow and colleagues briefly review this complex anatomical–functional interaction, a very useful historical summary. As we previously pointed out, history helps in understanding. This is the case here. Why? John Barlow started from the clinical observation and examination of patients with a mid-systolic click and late systolic murmur and palpitations, based on his interest in cardiac sounds, before echocardiography. From there, the Barlow valve has been established as individual entity. Modern echocardiography has helped to better understand the sequence of events until mitral regurgitation becomes significant., Surgical experiences with follow-up outcomes allowed us to confirm these valves are amenable for repair. Additional investigations showed that pathoanatomic changes in the form of annular abnormalities like disjunction should not be separated from the disease complex. The annular “instability” also may play a role in the development of ventricular arrhythmias. There is ongoing research regarding genetic etiology in mitral valve prolapse, something unknown with few genes identified. Van Wijngaarden and colleagues suggest some association between cardiomyopathy genes and prolapse, needing further investigation. Surgery of the Barlow valve aims at restoring competence, releasing leaflet tension, and achieving leaflet coaptation. Another issue is like in other repairs what may eventually happen with the left ventricle or if surgery should be performed before significant regurgitation develops. Considering the Barlow valve, symmetry is also an issue, as there is bileaflet billowing and prolapse. The disease cannot easily be replicated as a regular P2 prolapse in a model for bench simulation. Imbrie-Moore and colleagues developed a cross-species model of the disease for biomechanical analyses of repair techniques in an ex vivo model. With all the limitations in mind, it may help improving knowledge and test the ability to repair. This elegant and comprehensive historical review of Barlow and colleagues on the Barlow valve is another call for attention to the importance of reviewing history to understand the present and imagine the future.
  16 in total

1.  Some observations on the atrial sound.

Authors:  J B BARLOW
Journal:  S Afr Med J       Date:  1960-10-15

2.  Bileaflet repair for barlow syndrome.

Authors:  Ani C Anyanwu; David H Adams
Journal:  Semin Thorac Cardiovasc Surg       Date:  2010

3.  Barlow's Mitral Valve Disease: A Comparison of Neochordal (Loop) and Edge-To-Edge (Alfieri) Minimally Invasive Repair Techniques.

Authors:  Jaqueline G da Rocha E Silva; Ricardo Spampinato; Martin Misfeld; Joerg Seeburger; Bettina Pfanmüller; Sandra Eifert; Friedrich W Mohr; Michael A Borger
Journal:  Ann Thorac Surg       Date:  2015-08-12       Impact factor: 4.330

4.  Three-dimensional assessment of mitral valve annulus dynamics and impact on quantification of mitral regurgitation.

Authors:  Suzanne E van Wijngaarden; Vasileios Kamperidis; Madelien V Regeer; Meindert Palmen; Martin J Schalij; Robert J Klautz; Jeroen J Bax; Nina Ajmone Marsan; Victoria Delgado
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-02-01       Impact factor: 6.875

5.  Minimally invasive mitral valve repair in Barlow's disease: early and long-term results.

Authors:  Michael A Borger; Anna F Kaeding; Joerg Seeburger; Serguei Melnitchouk; Michael Hoebartner; Michael Winkfein; Martin Misfeld; Friedrich W Mohr
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-10       Impact factor: 5.209

6.  Identification of known and unknown genes associated with mitral valve prolapse using an exome slice methodology.

Authors:  Aniek L van Wijngaarden; Yasmine L Hiemstra; Tamara T Koopmann; Claudia A L Ruivenkamp; Emmelien Aten; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Daniela Q C M Barge-Schaapveld; Nina Ajmone Marsan
Journal:  J Med Genet       Date:  2020-04-10       Impact factor: 6.318

7.  Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation.

Authors:  Maurice Enriquez-Sarano; Rakesh M Suri; Marie-Annick Clavel; Francesca Mantovani; Hector I Michelena; Sorin Pislaru; Douglas W Mahoney; Hartzell V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  2015-04-09       Impact factor: 5.209

8.  "Respect when you can, resect when you should": A realistic approach to posterior leaflet mitral valve repair.

Authors:  Gilles D Dreyfus; Filip Dulguerov; Cecilia Marcacci; Shelley Rahman Haley; Antonia Gkouma; Carine Dommerc; Adelin Albert
Journal:  J Thorac Cardiovasc Surg       Date:  2018-05-28       Impact factor: 5.209

9.  A novel cross-species model of Barlow's disease to biomechanically analyze repair techniques in an ex vivo left heart simulator.

Authors:  Annabel M Imbrie-Moore; Michael J Paulsen; Yuanjia Zhu; Hanjay Wang; Haley J Lucian; Justin M Farry; John W MacArthur; Michael Ma; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2020-02-19       Impact factor: 5.209

10.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Authors:  Catherine M Otto; Rick A Nishimura; Robert O Bonow; Blase A Carabello; John P Erwin; Federico Gentile; Hani Jneid; Eric V Krieger; Michael Mack; Christopher McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson; Christopher Toly
Journal:  Circulation       Date:  2020-12-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.